Overview Medvest was established in 2010 as a UK based management partnership investing in selected Israeli life science companies, specifically medical devices. Our current portfolio contains 4 companies with novel technologies and IP that make revolutionary "Quality of Life" contributions. Medvest's vision is to provide our portfolio companies with financing, business leadership and guidance, turning them into fast growing and fully commercialised businesses. Medvest moved to phase 2 of its strategy at the beginning of 2015 developing and commercialising novel pharmaceutical and biotechnology products. A proven management team seeking to raise EUR12m to fund identified next steps.